Table of Contents
- The review that usually happens too late
- Why mid-year health plan reviews matter
- What employers usually receive
- 7 things employers should review mid-year
- Questions employers should ask during a mid-year review
- Red flags that may indicate overspending
- What a transparent mid-year review should look like
- How proactive plan management helps before renewal season
- Good health plans are managed all year
- Key takeaways
The review that usually happens too late
Most employers take a close look at their health plan during renewal season. That is when the broker brings updated numbers, the carrier or vendor shares projections, and the employer has to make decisions about the next plan year.
By that point, several cost drivers may already be sitting inside the plan.
Prescription costs may have climbed for months, a few high-cost medications may be changing the pharmacy budget, employees may be skipping care because of out-of-pocket costs, preventive-care use may be low and vendors may be sending reports that show numbers without explaining what needs attention.
A mid-year health plan review gives employers time to ask better questions before renewal pressure starts.
The goal is simple: understand what is happening inside the plan now, where costs are building, and which conversations need to happen before renewal season.
A useful review does not need to feel complicated. Employers need clear reporting, direct explanations, and practical next steps. They need to know what is driving spend, what employees are experiencing, and where vendors should be held accountable.
Why mid-year health plan reviews matter
Healthcare and pharmacy costs can change throughout the year. A plan that looked manageable in January may look different by June or July.
Pharmacy spend can shift when employees start new specialty medications, GLP-1s, diabetes drugs, or chronic-condition medications. Medical spend can shift when emergency room use increases, preventive care stays low, or one high-cost claim changes the conversation.
A mid-year review helps employers look at these patterns before renewal season.
It can show where the plan is spending more than expected and it can also show where employees may be struggling with access, affordability, or understanding their benefits.
Employers should use this review to ask direct questions:
- Which claims categories are growing?
- Which medications are driving pharmacy spend?
- Are employees using preventive care?
- Are employees delaying treatment because of cost?
- Are vendors explaining the numbers clearly?
- Are there plan-management changes that should be discussed now?
These questions give employers more time to prepare. Renewal season moves quickly, and rushed decisions can leave savings opportunities, plan-design issues, and employee concerns unresolved.
A mid-year review gives the employer a clearer view of the plan before those decisions arrive.
What employers usually receive instead
Many employers receive a basic renewal update near the end of the plan year. The update may include utilization summaries, renewal projections, and a few high-level notes about claims activity.
That type of reporting can leave employers with more questions than answers.
A report may show that pharmacy spend increased, but it may not explain which drug categories caused the increase. A report may show higher medical utilization, but it may not explain whether the increase came from emergency room visits, chronic-condition claims, preventive-care gaps, or one high-cost claimant.
Employers need more than numbers on a spreadsheet. They need someone to explain what the numbers mean for the plan.
A useful mid-year review should answer direct questions:
- Where is the plan spending more than expected?
- Which claims patterns need attention now?
- Are employees using the plan in costly ways?
- Are prescription costs creating avoidable pressure?
- Are vendors giving enough visibility into medical and pharmacy spend?
- Are there changes worth discussing before renewal season?
Generic reports make it harder for employers to act early. Clear reporting gives the employer a better starting point for plan-management conversations.
7 things employers should actually review mid-year
Pharmacy spend trends
Pharmacy spend deserves close attention during a mid-year review because it can move quickly.
Employers should ask whether prescription costs are increasing faster than expected. They should also ask which categories are driving the increase. For example, the plan may be seeing higher costs from diabetes medications, GLP-1s, specialty drugs, autoimmune treatments, or chronic-condition medications.
The review should also show whether the plan is paying more because of higher utilization, higher drug prices, new prescriptions, or a small number of high-cost claims.
For self-funded and level-funded plans, pharmacy spend is one of the areas where the right partner can make a direct difference. Intercept Rx offers an Rx Optimization Program designed to help employers lower prescription drug costs, support members, and provide many medications at a $0 copay with free home delivery.
A clear pharmacy review should help the employer understand:
- Which medications are driving spend
- Which drug classes are growing
- Whether specialty medications are changing the budget
- Whether members are filling medications consistently
- Whether lower-cost options should be reviewed
- Whether an Rx Optimization Program could reduce avoidable pharmacy spend
Pharmacy costs can become a major renewal issue when nobody looks at them until the end of the year. A mid-year review gives the employer time to ask questions before those costs shape the renewal conversation.
High-cost medications
A small number of prescriptions can create a large share of pharmacy spend.
That is common with specialty medications, GLP-1s, cancer treatments, autoimmune drugs, and medications tied to chronic conditions. Employers do not need to know private employee details. They need enough information to understand which categories are affecting the plan.
A mid-year review should look at high-cost medications in a practical way:
- Which medications are creating the highest spend?
- Are those prescriptions new or ongoing?
- Are there alternative sourcing options?
- Are there lower-cost options that should be reviewed?
- Are members receiving support to stay on necessary medications?
- Is the PBM explaining the pricing clearly?
This section of the review should help employers understand whether pharmacy spend is being managed with enough attention. It should also show whether the current strategy gives the plan enough visibility into cost, access, and member experience.
Employee utilization patterns
Employee utilization shows how people are using the health plan.
A mid-year review should look at patterns such as emergency room visits, urgent care use, primary care visits, preventive screenings, and telehealth use. These patterns can point to plan-design issues, communication gaps, or access problems.
For example, higher emergency room use may suggest that employees do not know where to go for lower-cost care. Low preventive-care use may suggest that employees need clearer reminders about covered services. Low primary care use may suggest that employees are waiting until problems become more expensive to treat.
Employers should ask:
- Are employees using primary care?
- Are emergency room visits increasing?
- Are urgent care visits replacing preventable emergency room claims?
- Are employees using preventive services?
- Are certain benefits being ignored?
- Are employees confused about where to go for care?
Utilization patterns give employers a clearer view of how the plan is working for employees day to day.
Specialty drug exposure
Specialty drugs can create large pharmacy claims and long-term cost pressure.
A mid-year review should show whether the plan has current specialty drug exposure and whether new specialty claims are likely to affect the next renewal. Employers should also ask how specialty drugs are being priced, managed, and reported.
The review should include:
- Current specialty drug spend
- New specialty prescriptions
- Ongoing specialty medication use
- Drug categories driving spend
- Member support programs
- Pricing transparency
- Available cost-management options
Specialty drug reporting should be clear enough for the employer to understand the plan’s exposure without getting buried in claim-level details.
Out-of-pocket burden on employees
Health plan costs affect the employer and the employee.
A mid-year review should look at what employees are paying when they use the plan. High copays, deductibles, and prescription costs can cause employees to delay care or abandon medications.
Employers should review:
- Prescription copays
- Deductible exposure
- Specialty medication affordability
- Cost barriers at the pharmacy counter
- Employee complaints about coverage
- Refill patterns for chronic-condition medications
This part of the review helps employers see where cost-sharing may be creating problems. For example, employees may skip maintenance medications when the price feels too high. That can lead to more claims activity later, especially for chronic conditions such as diabetes, hypertension, and asthma.
A good review should connect employee affordability with plan behavior. When employees cannot afford care, the plan may see more emergency claims, delayed treatment, and lower medication adherence.
Preventive care gaps
Preventive care can help catch health issues earlier and reduce avoidable claims later.
A mid-year review should look at whether employees are using annual wellness visits, screenings, immunizations, and chronic-condition checkups. Low use may mean employees do not understand what is covered or do not know how to access care.
Employers should ask:
- Are employees completing annual wellness visits?
- Are preventive screenings being used?
- Are chronic-condition checkups happening?
- Are employees using covered preventive services?
- Are there communication gaps around available benefits?
This does not need to turn into a complex clinical review. The employer needs a clear view of where preventive-care use is low and what can be communicated better during the rest of the year.
Vendor performance and accountability
A mid-year review should also examine how vendors are performing.
Brokers, PBMs, TPAs, carriers, and other partners should provide clear reporting and practical guidance. Employers should know whether vendors are explaining cost drivers, answering questions, and helping prepare for renewal.
Employers should ask:
- Are reports easy to understand?
- Are vendors explaining why costs are changing?
- Are promised savings showing up in the plan?
- Is pharmacy spend being reviewed clearly?
- Is medical utilization being explained?
- Are vendors bringing plan-management ideas before renewal season?
- Are employers getting answers without having to chase them?
Vendor accountability matters because employers rely on partners to interpret the plan. A mid-year review should make it clear whether those partners are bringing useful information or only sending reports.
Questions employers should ask during a mid-year review
A mid-year review should give employers a clear list of questions to bring to their broker, PBM, TPA, or carrier.
Start with the basics:
- What are the biggest drivers of our healthcare spend right now?
- Which prescription drugs are affecting pharmacy costs the most?
- Are specialty medications creating new cost pressure?
- Are employees using emergency rooms for avoidable care?
- Are employees using preventive services?
- Are employees struggling with prescription affordability?
- Are chronic-condition claims increasing?
- Are there any high-cost claims affecting the plan’s outlook?
- Are vendors explaining the data clearly?
- What should we address before renewal season?
These questions help employers move the conversation from a basic update to a practical review of plan performance.
The goal is to understand what needs attention now, what can wait, and what may affect renewal discussions later in the year.
Red flags that may indicate overspending
A mid-year review may reveal warning signs that the plan needs closer attention.
Some red flags include:
- Pharmacy spend rising faster than expected
- Specialty drug costs increasing without clear explanation
- High emergency room use
- Low preventive-care participation
- Rising employee complaints about prescription costs
- Limited visibility into medical claims
- Limited visibility into pharmacy claims
- Vendor reports with little explanation
- No clear plan for managing high-cost medications
- No mid-year reporting process
- Renewal discussions focused only on premium increases
These signs point to areas that need clearer answers from brokers, PBMs, TPAs, or carriers.
For example, a large claim may be unavoidable. A pattern of avoidable emergency room visits may point to an education issue. Higher pharmacy spend may come from necessary medications. It may also point to pricing, sourcing, or formulary concerns that need review.
The mid-year review should help separate routine claims activity from areas that need action.
What a transparent mid-year review should look like
A transparent mid-year review should be clear, specific, and useful.
Employers should be able to understand what is happening without sorting through pages of unexplained data. The review should give enough detail to support better decisions without overwhelming the employer.
A strong review should include:
- Clear medical and pharmacy spend summaries
- Main cost drivers
- High-cost medication review
- Specialty drug exposure
- Preventive-care use
- Employee cost-sharing concerns
- Utilization patterns
- Vendor-performance notes
- Renewal risks to watch
- Practical next steps
The review should also explain what the employer can do with the information.
For example, if preventive-care use is low, the next step may be an employee communication campaign. If specialty drug costs are rising, the next step may be a deeper PBM review. If emergency room use is high, the next step may be clearer education around primary care, urgent care, and telehealth options.
Employers should leave the review knowing which issues need attention, which questions need follow-up, and which vendors need to provide clearer answers.
How proactive plan management helps before renewal season
Renewal season puts employers on a short timeline. Decisions about plan design, contributions, vendors, pharmacy strategy, and employee communication often happen quickly.
Mid-year plan management gives employers more time.
They can review cost drivers earlier, ask vendors for clearer answers, compare pharmacy options, address employee confusion and prepare leadership before renewal numbers arrive.
A proactive review can help employers:
- Identify cost drivers earlier
- Review pharmacy spend before renewal pressure starts
- Spot employee affordability concerns
- Ask vendors for better reporting
- Prepare for high-cost claims conversations
- Review plan-design concerns
- Create clearer employee communication
- Enter renewal season with fewer surprises
This gives the employer a better foundation for renewal discussions. The conversation becomes more specific because the employer already knows which areas need attention.
Good health plans are managed all year
A health plan should not sit untouched for most of the year.
Costs change, employees use the plan in different ways, pharmacy trends shift, specialty medications appear, preventive-care gaps grow and vendors may send reports without explaining what needs attention.
A mid-year review gives employers a chance to look at the plan before renewal season sets the timeline.
The review should answer simple questions:
- What is driving spend?
- What are employees experiencing?
- Where are costs building?
- Which vendors need to explain more?
- What should be reviewed before renewal?
A useful mid-year review gives employers clear information, direct questions, and practical next steps before renewal season.
Key Takeaways
- Renewal season should not be the first close review of the health plan.
- Pharmacy spend, specialty medications, and high-cost claims should be reviewed mid-year.
- Employee utilization patterns can show where communication or access issues exist.
- Out-of-pocket costs can affect how employees use care and medications.
- Vendor reporting should explain what the numbers mean.
- A mid-year review gives employers more time to prepare for renewal decisions.
